Pharmaceutical News

RSS

MDMA appears to help in treating PTSD patients

When lasting trauma is caused by callous acts of violence, the key to recovery can be making meaning out of meaninglessness.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Majority of prescription drug commercials focus on lifestyle improvements, study finds

Prescription drug commercials are getting longer and providing less factual information. A study published in the Annals of Family Medicine finds that the majority of these ads focus on lifestyle improvements made post-medication rather than side-effects and the negative emotions associated with certain health issues.

15 May 2018

Opioid pharmaceutical marketing influences physicians' opioid prescribing rates

A new study shows the significant impact that even a meal or two paid for by a pharmaceutical company can have on prescribing rates, despite a national decline of opioid prescribing rates.

15 May 2018

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics.

15 May 2018

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Study: Effective intervention can reduce medication overuse in aged care facilities

Effective intervention can reduce medication overuse in Residential Aged Care Facilities, the latest University of Tasmania research shows.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

President Donald Trump didn't mention Novartis or other drugmakers by name last year when he said the industry is "getting away with murder."

11 May 2018

$Osteoporosis drug may be cardioprotective in hip fracture patients$

Osteoporosis drug may be cardioprotective in hip fracture patients

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture.

11 May 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

Study finds inappropriate prescriptions given to many older adults discharged from hospital

In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.

11 May 2018

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Data from a new survey show that as many as 80% of oncologists have discussed medical marijuana use with their patients.

11 May 2018

Oral antibiotic use may increase risk of developing kidney stones, shows study

Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones.

11 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

New study links oral antibiotics with increased risk of kidney stones

The potential to promote antibiotic resistance in bacteria isn't the only reason to avoid using antibiotics when possible.

11 May 2018

Using opioid-sparing pain management techniques to better prevent addiction and abuse

Over 2 million people each year switch to persistent opioid use after surgery, and nearly half of all U.S. opioid overdose deaths involve a prescription opioid.

10 May 2018

ICON announces results of new survey that examines key challenge of R&D efficiency

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the results from a new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development efficiency

9 May 2018

Giving identical subsidies can get gold-standard medications into the hands of consumers

Equal subsidies "surprisingly powerful," in promoting use of gold-standard medications, new study shows.

9 May 2018

Pharmaceutical News

MDMA appears to help in treating PTSD patients

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Majority of prescription drug commercials focus on lifestyle improvements, study finds

Opioid pharmaceutical marketing influences physicians' opioid prescribing rates

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Study: Effective intervention can reduce medication overuse in aged care facilities

FDA approves new drug to treat MS in pediatric patients

Trump vows (again) to lower drug prices but skeptics doubt much will change

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

Osteoporosis drug may be cardioprotective in hip fracture patients

Oral drug reduces venous thromboembolism recurrence among cancer patients

Study finds inappropriate prescriptions given to many older adults discharged from hospital

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Oral antibiotic use may increase risk of developing kidney stones, shows study

Addressing Antimicrobial Resistance Through Industry

New study links oral antibiotics with increased risk of kidney stones

Using opioid-sparing pain management techniques to better prevent addiction and abuse

ICON announces results of new survey that examines key challenge of R&D efficiency

Giving identical subsidies can get gold-standard medications into the hands of consumers

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News